Dominion Energy Inc (D) Stock News

Abbott Laboratories is positioned for significant growth potential, with analyst projections suggesting the stock could reach approximately $210 per share by 2036 based on conservative 8% annual earnings growth. The healthcare company's strong track record includes a 9.7% compound annual earnings-per-share growth rate over the past decade, bolstered by strategic acquisitions. Abbott's status as a Dividend King with 54 consecutive years of dividend increases, combined with a 2.5% dividend yield, makes it an attractive option for income-focused investors seeking defensive holdings with upside potential.

SoundHound AI has significantly expanded its enterprise opportunity through the acquisition of LivePerson. The key question for investors is whether the company can successfully convert this larger customer base into cross-selling opportunities, higher recurring revenue, and improved financial performance before mounting losses, declining legacy revenue, and shareholder dilution undermine the investment thesis.

Viking Therapeutics is advancing its oral weight-loss drug VK2735 to Phase 3 trials, showing 12.2% weight loss in Phase 2 testing. However, the company faces significant competitive challenges from established players like Eli Lilly's Foundayo, which demonstrated better tolerability with lower discontinuation rates. While Viking's injectable formulation shows promise with potential monthly dosing differentiation, the biotech will struggle to gain market traction in an increasingly crowded obesity drug market dominated by incumbents.

D-Wave Quantum Inc. (NASDAQ: QBTS) is under investigation for potential federal securities law violations following disappointing Q2 2026 financial results with revenue of $3.08 million, missing analyst expectations of $4.03-$4.08 million. The company's stock fell over 9% on August 6, 2026, and again on August 26, 2026, following the announcement of its CFO's resignation. Kessler Topaz Meltzer & Check, LLP is encouraging affected investors to contact the firm regarding potential legal claims.

Coinbase CEO Brian Armstrong reaffirmed his $400,000 Bitcoin price target by 2030 during a podcast interview, citing the cryptocurrency's four-year halving cycle. However, the article argues this target is unrealistic, requiring 48.2% annual compounding over four years and a market cap of $8.2 trillion—roughly five times today's value. While Armstrong's long-term logic about fixed supply and adoption is sound, the specific 2030 deadline appears overly optimistic given Bitcoin's shrinking cycle peaks.

The article recommends four consumer staples companies as long-term dividend investments: Procter & Gamble, Coca-Cola, Colgate-Palmolive, and Hershey. All four have decades of consistent dividend payments, strong brand portfolios, and generate sufficient free cash flow to sustain and grow their dividends through economic cycles.

Rosen Law Firm is urging investors who purchased Doximity common stock between August 8, 2024 and May 13, 2026 to join a securities class action lawsuit before the November 16, 2026 lead plaintiff deadline. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed feature, lost market share to competitors, and relied on less effective engagement tactics, causing investor damages when the truth emerged.

A securities fraud class action lawsuit has been filed against Duolingo, Inc. for investors who purchased stock between May 2, 2025 and February 26, 2026. The lawsuit alleges material misstatements regarding monetization strategies and user friction that negatively impacted daily active user (DAU) growth. Duolingo's stock declined significantly following disappointing Q3 results (DAU growth fell to 36% from 49%), a CFO resignation, and weak Q4 guidance showing only 20% DAU growth for 2026.

The Vanguard Information Technology ETF (VGT) has delivered exceptional returns of 839% over the past decade with a 25.1% annualized gain, outperforming the Invesco QQQ Trust's 586% return and 21.3% annualized gain. With a low expense ratio of 0.09% and $170 billion in assets, VGT offers broad exposure to over 300 technology stocks, with top holdings in Nvidia (17.7%), Apple (15.8%), and Microsoft (11.5%), positioning investors to benefit from AI's economic impact.

AI power demand is expected to double between 2024 and 2030, reaching 945 terawatt-hours annually. This massive growth in electricity consumption presents significant investment opportunities across the power and cooling supply chain, benefiting companies that provide fuel cells, electrical components, cooling systems, turbines, and utility services.

A class action lawsuit has been filed against Aardvark Therapeutics in the U.S. District Court for the Southern District of California. The lawsuit alleges that defendants made materially false and misleading statements in the company's IPO registration statement and throughout the class period (February 13, 2025 to May 14, 2026), specifically regarding the safety and commercial prospects of their drug ARD-101. Investors who purchased shares during this period can apply to be lead plaintiff by October 13, 2026.

A class action lawsuit has been filed against The Simply Good Foods Company for allegedly making false statements regarding its OWYN acquisition. The lawsuit claims the company lost key personnel post-acquisition, faced product quality issues with a new pea protein supplier, engaged in excessive discounting to boost sales, and ultimately failed to achieve strategic goals, resulting in significant operational and financial problems for the OWYN segment.

Rosen Law Firm is urging UWM Holdings Corporation investors who purchased securities between March 9, 2026 and August 5, 2026 and suffered losses exceeding $100,000 to join a securities class action lawsuit before the October 13, 2026 lead plaintiff deadline. The lawsuit alleges that UWM Holdings made materially false statements regarding its hedging strategy for mortgage servicing rights, claiming the company deviated from its traditional non-hedging approach and over-hedged in anticipation of the Two Harbors transaction, creating excess hedging risk.

Vannor launched its agentic marketing platform featuring autonomous AI agents that manage end-to-end marketing workflows on proprietary NVIDIA infrastructure. The company reported a 30-fold increase in first-page Google rankings and a 554% increase in weekly search impressions within one month of deployment. The system operates across search content, paid advertising, landing pages, and social media while maintaining brand consistency and data privacy.

PayPal has initiated a dividend program and is aggressively returning cash to shareholders through stock buybacks, returning 70-80% of free cash flow. Despite a 79% stock decline over five years, the company maintains strong profitability. The article suggests PayPal could see strong rebound momentum from growth initiatives, efficiency improvements, and a potential acquisition within five years, as it trades at a cheap valuation of 10x expected earnings.

Johnson & Johnson and Realty Income are recommended as long-term dividend stocks. J&J, a Dividend King with 64 consecutive years of dividend increases, offers defensive healthcare stability through its innovative medicine and medtech businesses. Realty Income, with 136 monthly dividend increases, provides predictable income through its diversified commercial real estate portfolio with strong occupancy and expansion into data centers and private capital partnerships.

Alphabet's Google Cloud revenue surged 82% to $24.8 billion in Q2, significantly outpacing search revenue growth of 17%. With 950 million Gemini app users and a $514 billion revenue backlog, Google Cloud is emerging as a primary growth driver for Alphabet's AI-focused future, though search still accounts for over half of total revenue.

The 10-year U.S. Treasury yield reached 5.36% on October 7, 2026, its highest level since 2002, driven by persistent inflation, Federal Reserve rate hikes, a large federal budget deficit, and competition from AI infrastructure debt. With high Treasury yields making stocks less attractive, history suggests investors should focus on high-quality dividend-growth stocks with inflation-protected cash flows rather than stocks dependent on low rates.

Palantir Technologies stock surged 60% in Q3 2026, marking its sixth quarter with 40%+ gains since going public in 2020. Historical analysis shows the stock continued rising in four of five previous big quarters, though the pattern is limited. The company's revenue growth accelerated to 93% year-over-year in Q2 2026, though Q3 guidance suggests a slowdown to 83%. Despite strong business fundamentals, the author notes the stock's 165x earnings valuation is too high to justify buying at current levels.

A securities class action lawsuit has been filed against HDFC Bank Limited for allegedly making materially false statements regarding its financial operations. The bank is accused of camouflaging payments as marketing spend to pay higher interest to a state firm to induce deposits, with activities allegedly approved by senior management and potentially violating regulations. Investors who purchased HDFC Bank securities between July 17, 2023 and May 26, 2026 may be eligible for compensation, with a lead plaintiff deadline of October 13, 2026.

GigaCloud Technology (GCT) is a rapidly growing logistics and e-commerce company specializing in storage, distribution, and delivery of large, bulky products. The company reported 28% YoY revenue growth to $411.6M in Q2 with 45% EPS growth. Trading at 11.5x forward earnings with projected 23.4% revenue growth and 37.1% earnings growth this year, GCT recently broke out to new all-time highs. Despite strong fundamentals and limited analyst coverage, the stock presents an attractive growth opportunity.

Shoe Station Group Inc. (SHOE), a major U.S. family footwear retailer, continues to struggle with declining sales, contracting margins, and deteriorating profitability. Despite a 66% stock decline over two years, shares remain overvalued at 15.4x forward earnings. Analyst earnings estimates have plummeted 43.3% for the current year, and the company has been downgraded to Zacks Rank #5 (Strong Sell). With no clear evidence of a business turnaround, the stock faces additional downside risk.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against AppLovin Corporation (NASDAQ: APP) on behalf of investors who purchased securities between February 12, 2026 and August 5, 2026. The lawsuit alleges that AppLovin made false and misleading statements regarding its generative AI video creative feature, overstating AI model improvements and the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

Rosen Law Firm is urging investors who purchased Beta Bionics common stock between July 30, 2025 and February 24, 2026 to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made materially false and misleading statements about its iLet Bionic Pancreas insulin pump, which the FDA found was malfunctioning and dosing patients with dangerously high insulin levels. The firm claims thousands of complaints were filed with the FDA, contradicting defendants' assertions that issues were benign. The lead plaintiff deadline is November 3, 2026.

Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 9, 2026 merger. The lawsuit alleges that merger offering materials misrepresented regulatory compliance efforts and omitted material information about defendants' undisclosed hiring of Trump-connected lobbyists and lawyers to obtain backdoor access to DOJ officials to circumvent standard merger review processes. The complaint claims these practices contradicted attestations of 'reasonable best efforts' for regulatory approval and allowed the merger to close despite anticompetitive effects. The deadline to serve as lead plaintiff is December 8, 2026.

MannKind Corporation announced new clinical data for Furoscix ReadyFlow, an autoinjector delivering IV-equivalent diuretic therapy for heart failure and chronic kidney disease. Presented at the HFSA 2026 Annual Scientific Meeting, the data demonstrates comparable urine output to IV furosemide, consistent bioavailability across injection sites, and seamless transition capabilities from the previous On-body Infusor formulation. The product received FDA approval in July 2026 and is designed to enable earlier outpatient intervention for fluid overload management.

Brookfield Infrastructure Corporation (BIPC) has rescheduled its shareholder meeting to October 29, 2026, to allow additional time for voting on a proposed corporate simplification. The plan would combine Brookfield Infrastructure Partners L.P. (BIP) and BIPC into a single publicly traded corporation called Brookfield Infrastructure Partners Inc. (BIP Inc.). Votes received to date show strong support, and both company boards unanimously recommend approval. The simplification is expected to be tax-deferred and completed in Q4 2026 if approved.

Coastal Community Bank announced its investment in Koz Development's PNW Attainable Workforce Housing Fund, which aims to expand high-quality, environmentally responsible housing for working individuals and families across Washington and Oregon. The fund targets the 'missing middle'—households earning too much for traditional assistance but struggling with market-rate housing affordability. In Washington, the investment also supports Koz developments in the Ballmer Group's Washington Family Housing Fund partnership.

Brookfield Infrastructure Corporation (BIPC) has rescheduled its shareholder meeting to October 29, 2026, to allow additional time for voting on a proposed corporate simplification. The plan would combine Brookfield Infrastructure Partners L.P. (BIP) and BIPC into a single publicly traded corporation called Brookfield Infrastructure Partners Inc. (BIP Inc.). Votes received to date show strong support, and both company boards unanimously recommend approval. The simplification is expected to be tax-deferred and completed in Q4 2026 if approved.

Rosen Law Firm has filed a class action lawsuit against Coastal Financial Corporation (CCB) on behalf of investors who purchased common stock between October 28, 2024 and July 29, 2026. The lawsuit alleges that defendants misrepresented and failed to disclose key facts concerning credit risks associated with Coastal Financial's CCBX business, including exposure to credit losses and the effectiveness of contractual indemnification protections. Investors who wish to serve as lead plaintiff must move the Court by December 1, 2026.